Skip to main content

Table 4 Comparison of EQ-5D and SF-6D in patient subgroups where there were expected improvements in health status

From: Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain

Patient subgroup EQ-5D change from baseline SF-6D change from baseline
Patients who completed the trial and had no adverse events 0.252 0.094
Patients who completed the trial and had >30% pain relief 0.286 0.113
Patients with at least one AE 0.157 0.049
Patients with an AE that lead to withdrawal 0.073 0.005
Patients who discontinued therapy due to lack of efficacy 0.032 0.006